Overall, curcumin promotes ferroptosis and inhibits CRC cell growth via suppression of the PI3K/AKT/mTOR pathway, highlighting its potential as a therapeutic agent for CRC [130]. The gene discussed is AKT1; the disease is colorectal carcinoma.